This inventor holds 7 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 8 EPO patents. Top assignees: Lofarma S.p.a., Consiglio Nazionale Delle Ricerche, Laboratorio Farmaceutico Lofarma S.r.l.. Active years: 1994-2020.
Company Filing History:
4 out of 6 
2 out of 325 
1 out of 1 Years Active: 1994-2020
Title: Paolo Falagiani: Innovator in Allergy Treatment
Introduction
Paolo Falagiani is a prominent inventor based in Milan, Italy. He has made significant contributions to the field of allergy treatment, holding a total of 7 patents. His innovative work focuses on developing hypoallergenic variants and methods for reducing allergenicity while preserving immunogenicity.
Latest Patents
Falagiani's latest patents include a method for creating allergoids derived from allergens. This method involves modifying primary amine groups of lysine and arginine residues in native allergenic materials, such as DP mites extract and ovalbumin. The goal is to achieve reduced allergenicity while maintaining an effective immune response. Another notable invention provides hypoallergenic variants of the Bet v 1 major allergen from plant pollen, aimed at preventing or treating allergic diseases.
Career Highlights
Throughout his career, Falagiani has worked with reputable organizations, including Lofarma S.p.a. and the National Research Council of Italy. His expertise in allergy research has positioned him as a key figure in the development of innovative treatments.
Collaborations
Falagiani has collaborated with notable professionals in his field, including Giovanni Mistrello and Daniela Roncarolo. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Paolo Falagiani's work in allergy treatment exemplifies the impact of innovation in healthcare. His patents and collaborations highlight his commitment to improving the lives of those affected by allergies.